EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallbericht

Platelet-Derived Growth Factor-D Fusion-Positive Dermatofibrosarcoma Protuberans: Case Report of an Atypical Breast Mass and Literature Review

Blake Chandler, Frank Jing iD, Marjorie Parker David, Alia Nazarullah iD

International Journal of Surgical Pathology · 2023

DOI: 10.1177/10668969231160261 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Surgical Pathology, 2023. Verfasst von Blake Chandler und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Texas Health Long School of Medicine, San Antonio, TX, USA. Hauptthemen laut MEDLINE: Dermatofibrosarcoma, Skin Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dermatofibrosarcoma protuberans (DFSP) is a rare, CD34+ mesenchymal neoplasm that classically involves the dermis. A COL1A1::PDGFB t(17;22) translocation is present in 91.4% to 96% of cases, resulting in aberrant proliferation due to tyrosine kinase hyperactivity. Here, we present a postmenopausal woman with a CD34-positive spindle cell neoplasm of the breast without cutaneous involvement, lacking muscle marker expression, STAT6 expression, and 13q14 deletion by fluorescence in situ hybridization (FISH). Although the classic PDGFB translocation was not detected by FISH, the overall features were highly suspicious for DFSP. Subsequent RNA-based next-generation sequencing revealed an EMILIN2::PDGFD fusion. A literature review showed that PDGFD fusions can be detected in up to 55% PDGFB FISH negative cases, with EMILIN2::PDGFD fusion highly associated with fibrosarcomatous transformation. This holds important diagnostic and prognostic information as fibrosarcomatous-DFSP is associated with higher recurrence and metastatic potential. The tumor was completely resected with clear margins, showed no fibrosarcomatous areas, and no evidence of recurrence is documented 2 years since resection. This review and case report adds to the literature regarding PDGFD -translocation positive DFSP as a differential diagnosis of CD34-positive spindle cell tumors of the breast, while emphasizing the prognostic importance of EMILIN2::PDGFD fusions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatofibrosarcomaSkin NeoplasmsFemaleHumansIn Situ Hybridization, FluorescenceOncogene Proteins, FusionProto-Oncogene Proteins c-sisTranslocation, GeneticLymphokinesPlatelet-Derived Growth Factor

Stichwörter der Autor:innen

breastmolecular pathologysoft tissue

Substanzen

Oncogene Proteins, FusionProto-Oncogene Proteins c-sisPDGFD protein, humanLymphokinesPlatelet-Derived Growth Factor

Autor:innen und Institutionen

  • University of Texas Health Long School of Medicine, San Antonio, TX, USA.
  • Department of Pathology and Laboratory Medicine, University of Texas Health, San Antonio, TX, USA.

ORCID-Profile: Frank Jing, Alia Nazarullah

Zitieren

APA

Chandler, B., Jing, F., David, M. P., & Nazarullah, A. (2023). Platelet-Derived Growth Factor-D Fusion-Positive Dermatofibrosarcoma Protuberans: Case Report of an Atypical Breast Mass and Literature Review. International Journal of Surgical Pathology. https://doi.org/10.1177/10668969231160261

Vancouver

Chandler B, Jing F, David MP, Nazarullah A. Platelet-Derived Growth Factor-D Fusion-Positive Dermatofibrosarcoma Protuberans: Case Report of an Atypical Breast Mass and Literature Review. International Journal of Surgical Pathology. 2023. doi:10.1177/10668969231160261

BibTeX
@article{Chandler2023,
  author = {Chandler, Blake and Jing, Frank and David, Marjorie Parker and Nazarullah, Alia},
  title = {Platelet-Derived Growth Factor-D Fusion-Positive Dermatofibrosarcoma Protuberans: Case Report of an Atypical Breast Mass and Literature Review},
  journal = {International Journal of Surgical Pathology},
  year = {2023},
  doi = {10.1177/10668969231160261}
}
Kostenlos starten →